Program
08:15-08:45 Registration
08:45-09:00 Introduction: why and when of an active meeting among Centers
Session 1: Looking forward NETs
Chairs: F. de Braud, V. Mazzaferro
Discussants: V. Ambrosini, M. P. Brizzi, M. V. Davì, F. Grillo, S. Massironi, S. Partelli
09:00-09:20 Circulating tumor cells, DNA and MicroRNAs as prognostic markers for NETs – M. C. Zatelli
09:20-09:40 Recent update on diagnosis, clinical features and management of MENs – S. Glasberg
09:40-10:00 Current and future perspectives of radiometabolic therapies for neuroendocrine tumors – A.J.A.T. Braat
10:00-10:20 PRRT alone or in combination with other drugs? – N. Fazio
10:20-10:40 Surgery of GEP-NETs in oligometastatic disease – A. Frilling
10:40-11:00 Post-surgical monitoring of curatively resected GEP-NETs – V. Mazzaferro
11:00-11:30 Coffee break
Session 2: Video Presentation
Chairs: A. Frilling, V. Mazzaferro
11:30-12:00 Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for the treatment of pNETs
Presenters: F. Cavalcoli, G. Delconte
Discussant: A. Larghi
12:00-12:30 Radioembolization in syndromic patients with liver metastases refractory to therapy
Presenters: M. Maccauro, N. Prinzi, C. Spreafico
Discussant: I. Bargellini
12:30-13:00 Indications for laparoscopic pNET resections
Presenters: C. Sposito, M. Virdis
Discussant: G. Butturini
13:00-14:00 Lunch
Session 3: Web multimodal Tumor Board
WEB-CONNECTED CENTERS: Catania, Napoli, Roma e Verona
Board coordinators and question makers: N. Fazio, J. Coppa
14:00-15:30 Tumor board 1
Participants: R. Baldelli, C. Cotsoglou, R. Lanocita, M. Milione, S. Pusceddu, E. Seregni, F. Spada
Retroperitoneal pheochromocytoma
Therapy-resistant insulinoma
pNET liver metastases
Paraneoplastic syndrom in a lung carcinoid
15:30-17:00 Tumor board 2
Participants: M. Albertelli, M. Bongini, C. Carnaghi, T. Cascella, M. Milione, S. Pusceddu, F. Scalorbi, A. Versari
PRRT and loco-regional therapies
Cardias NEC G3
Analogue-based therapies
Urogenital NEC G3
17:00-17:30 Take-home messages and closure